Scarica l'app Stockscreener
5.16
4.27%
-0.23
Dopo l'orario di chiusura:
5.19
0.03
+0.58%
Precedente Chiudi:
$5.39
Aprire:
$5.38
Volume 24 ore:
1.18M
Relative Volume:
0.61
Capitalizzazione di mercato:
$917.77M
Reddito:
-
Utile/perdita netta:
$-45.44M
Rapporto P/E:
-14.74
EPS:
-0.35
Flusso di cassa netto:
$-42.28M
1 W Prestazione:
-6.69%
1M Prestazione:
+5.31%
6M Prestazione:
+114.11%
1 anno Prestazione:
+241.72%
Intervallo 1D:
$5.15
$5.43
Intervallo di 1 settimana:
$5.085
$5.755
Portata 52W:
$1.33
$5.86
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Confronta CMPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
5.16 | 958.68M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2025-12-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-12-03 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Wall Street Analysts Think Compass Therapeutics, Inc. (CMPX) Could Surge 134.14%: Read This Before Placing a Bet - Zacks Investment Research
An analyst sees good growth prospects for Compass Therapeutics Inc (CMPX) - Setenews
Vivo Capital LLC Purchases 2,487,443 Shares of Compass Therapeutics, Inc. $CMPX - MarketBeat
Here's Why Compass Therapeutics, Inc. (CMPX) is a Great Momentum Stock to Buy - Yahoo Finance
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Compass Therapeutics announces public offering of common stock By Investing.com - Investing.com Nigeria
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated at Citizens Jmp - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Now Covered by Analysts at Canaccord Genuity Group - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Citizens Jmp - Defense World
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World
Citizens Initiates Coverage of Compass Therapeutics (CMPX) with Market Outperform Recommendation - Nasdaq
Compass Therapeutics (NASDAQ:CMPX) Trading Down 6%Time to Sell? - MarketBeat
CMPX Analyst Rating Update: Citizens Initiates Coverage with Mar - GuruFocus
This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Cantor Fitzgerald Initiates Compass Therapeutics at Overweight - marketscreener.com
Cantor Fitzgerald initiates Compass Therapeutics stock with Overweight rating By Investing.com - Investing.com UK
Compass Therapeutics stock initiated at Market Outperform by Citizens - Investing.com Canada
The growth track for Compass Therapeutics Inc (CMPX) has changed recently - Setenews
Compass Therapeutics (NASDAQ:CMPX) Sets New 52-Week HighTime to Buy? - MarketBeat
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement - Insider Monkey
Compass Therapeutics stock hits 52-week high at 5.86 USD By Investing.com - Investing.com Nigeria
Compass Therapeutics stock hits 52-week high at 5.86 USD - Investing.com
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? - Yahoo Finance
Analysts Issue Forecasts for CMPX FY2025 Earnings - MarketBeat
A Look at Compass Therapeutics (CMPX) Valuation Following Strong CTX-10726 Preclinical Data and Management Update - Yahoo Finance
Compass Therapeutics (CMPX): Evaluating Valuation After a 55% 1-Month Share Price Surge - Sahm
Compass Therapeutics (NASDAQ:CMPX) Trading Up 8.1%Time to Buy? - MarketBeat
What analysts say about Compass Therapeutics Inc stockMACD Trading Signals & Free Daily Stock Hotspot Analysis - earlytimes.in
Compass Therapeutics Inc (CMPX) expanding its growth trajectory ahead - setenews.com
Q2 Earnings Forecast for CMPX Issued By Leerink Partnrs - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Rating Increased to Strong-Buy at Leerink Partnrs - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Raised to “Strong-Buy” at Leerink Partnrs - Defense World
Published on: 2025-11-28 14:33:59 - moha.gov.vn
What is Leerink Partnrs’ Estimate for CMPX Q2 Earnings? - Defense World
12 Hot Penny Stocks to Invest in Right Now - Insider Monkey
Compass Therapeutics, Inc. (CMPX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade - Finviz
Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here - sharewise.com
Compass Therapeutics to Participate in Upcoming December Investor Events - The Manila Times
Zacks.com featured highlights include Orla Mining, FIGS and Compass Therapeutics - sharewise.com
Will Compass Therapeutics Inc. stock outperform value stocksMarket Growth Review & Verified Technical Trade Signals - newser.com
2025's Top 3 Breakout Stocks for Active Traders: Don't Miss Out! - Zacks Investment Research
How Compass Therapeutics Inc. stock performs in weak economy2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Why Compass Therapeutics Inc. stock is rated strong buyStop Loss & Stepwise Trade Signal Implementation - newser.com
Can Compass Therapeutics Inc. recover in the next quarterJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Compass Therapeutics Inc Azioni (CMPX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):